MentionFox
Home › Executive changes › Cidara Therapeutics, Inc.
Leadership changes · CDTX · SEC Form 8-K, Item 5.02

Leadership changes at Cidara Therapeutics, Inc. (2026)

Before you join, sell to or invest in Cidara Therapeutics, Inc.

MentionFox check on Cidara Therapeutics, Inc.: only 2 sources on file so far (checked 14 November 2026). Run a full check before you rely on it. mentionfox.com/c/executive-changes/cidara-therapeutics

  • Note: Layoff plan disclosed Sep 2024 (about 20 employees) (filing)

New since last check: Layoff plan disclosed Sep 2024 (about 20 employees) (filing, first seen 14 November 2026).

Check Cidara Therapeutics, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Cidara Therapeutics, Inc.?

Who joined and who left Cidara Therapeutics, Inc. (CDTX)? 1 filing reported on 2026-01-07, each cited to the company's own filing.

As of November 14, 2026, Cidara Therapeutics, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on January 7, 2026 (Form 8-K, January 7, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

BCLS Fund III Investments, LP also filed stake reports on 3 other companies ↓

Sell to companies like Cidara Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Changes1
Latest filing2026-01-07

Cidara Therapeutics, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-01-07. Every row below is cited to the filing it comes from, and this page adds each new change as Cidara Therapeutics, Inc. files it.

Layoffs on record: about 20 jobs, latest 2024-09-12 (layoff filings and notices).

Also on the record for Cidara Therapeutics, Inc.

DateRecordFigureOur pageSource
February 17, 2026Stake report, Schedule 13G/A, by BCLS Fund III Investments, LP—5%+ stakesSource
February 17, 2026Stake report, Schedule 13G/A, by Point72 Asset Management, L.P.1.4% of the class5%+ stakesSource
February 13, 2026Stake report, Schedule 13G/A, by Vivo Opportunity Fund Holdings, L.P.—5%+ stakesSource
January 30, 2026Stake report, Schedule 13G, by The Vanguard Group6.38% of the class5%+ stakesSource
January 9, 2026Stake report, Schedule 13D/A, by RA Capital Management, L.P.—5%+ stakesSource
January 7, 2026Acquired by Merck Sharp & Dohme LLC—AcquisitionSource
November 17, 2025Stake report, Schedule 13D/A, by RA Capital Management, L.P.10.7% of the class5%+ stakesSource
November 14, 2025Stake report, Schedule 13G/A, by BCLS Fund III Investments, LP9.99% of the class5%+ stakesSource
November 14, 2025Stake report, Schedule 13G/A, by Commodore Capital LP2% of the class5%+ stakesSource
November 14, 2025Stake report, Schedule 13G/A, by Paradigm BioCapital Advisors LP3.3% of the class5%+ stakesSource
November 14, 2025Stake report, Schedule 13G/A, by Point72 Asset Management, L.P.6.2% of the class5%+ stakesSource
November 14, 2025Stake report, Schedule 13G/A, by TCG Crossover GP II, LLC—5%+ stakesSource

Selling to them or working with them? See who runs Cidara Therapeutics, Inc. now and the warning signs.

Free to see. No signup.

Keep reading

More on Cidara Therapeutics, Inc. and the records around it.

Cidara Therapeutics, Inc. elsewhere on the record

Companies that share a holder

Want the whole picture on Cidara Therapeutics, Inc.?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Cidara Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Cidara Therapeutics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    13 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The newest 12 of 26 records.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-01-07Reportednot named in the filing8-K, 2026-01-07
Selling to Cidara Therapeutics, Inc.?

New leaders reset buying decisions — get the Full Report on Cidara Therapeutics, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch Cidara Therapeutics, Inc.

Hiring for a seat like this?

Find people with the same kind of experience as the senior executive at Cidara Therapeutics, Inc., with the record behind each one.

Find candidates like senior executive at Cidara Therapeutics, Inc.

Every change, in the filing's words

Filed 2026-01-07 · 8-K

Reported

In accordance with the terms of the Merger Agreement, effective as of the Effective Time, (i) the directors of Purchaser as of immediately prior to the Effective Time, Jon Filderman, Melissa Leonard and Dalton Smart became the directors of the Company until the earlier of their resignation or removal or until their respective successors are duly designated, as the case may be, and each of Daniel Burgess, Bonnie Bassler, Carin Canale-Theakston, James Merson, Chrysa Mineo, Joshua Resnick, Theodore R. Schroeder, Ryan Spencer and Jeffrey Stein voluntarily resigned as directors of the Company and f

Also stated in this filing

  • Information with respect to the new officers and directors of the Company is set forth in Schedule I to the Offer to Purchase, a copy of which is attached as Exhibit (a)(1)(i) to the Schedule TO filed by Parent and Purchaser on December 5, 2025.

Tools for this story

Each opens in a new tab, filled in for Cidara Therapeutics, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/cidara-therapeutics
Last updated 2026-11-14
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
What changed at the top of Cidara Therapeutics, Inc.? (2026). MentionFox, 2026-11-14. https://mentionfox.com/executive-changes/cidara-therapeutics